Ignite Creation Date:
2024-05-05 @ 10:31 PM
Last Modification Date:
2024-10-26 @ 10:20 AM
Study NCT ID:
NCT01124734
Status:
COMPLETED
Last Update Posted:
2019-02-12
First Post:
2010-03-04
Brief Title:
High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma
Sponsor:
Milton S Hershey Medical Center
Organization:
Milton S Hershey Medical Center
Organization Data
Organization:
Milton S Hershey Medical Center
Class:
OTHER
Study ID:
PSHCI 09-067
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Milton S Hershey Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Joseph Drabick
Responsible Party Title:
Professor of Medicine
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Milton S Hershey Medical Center
Old Name:
None
Old Organization:
None